会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • CUTING BOARD FOR FOOD PRODUCTS
    • 食品食品委员会
    • WO2004093616A2
    • 2004-11-04
    • PCT/US2004/012148
    • 2004-04-20
    • JOHNSON, Tony, A.JOHNSON, Wayne, R.
    • JOHNSON, Tony, A.JOHNSON, Wayne, R.
    • A47J
    • A47J47/005
    • Disclosed is a cutting board, comprising a body. The body defines a cutting surface. The cutting surface comprises a plurality of apertures extending through the body and a support structure separating each adjacent aperture of the plurality of apertures. The plurality of apertures allows fluid to drain from the cutting surface while the support structure grips the food item to minimize slippage on the surface during a cutting motion. The support structure includes one or more gripping edges for gripping a food item to resist horizontal shear forces exerted on the cutting surface. The plurality of apertures and the support structure define a substantially open matrix.
    • 公开了一种切割板,包括主体。 主体定义切割表面。 切割表面包括延伸穿过主体的多个孔和分隔多个孔的每个相邻孔的支撑结构。 多个孔允许流体从切割表面排出,同时支撑结构握住食品以最小化在切割运动期间在表面上的滑动。 支撑结构包括用于夹紧食品以抵抗施加在切割表面上的水平剪切力的一个或多个抓握边缘。 多个孔和支撑结构限定基本上开放的矩阵。
    • 5. 发明申请
    • CYSTEINE PROTEASE INHIBITORS FOR USE IN TREATMENT OF IgE MEDIATED ALLERGIC DISEASES
    • 用于治疗IgE介导性过敏性疾病的CYSTEINE PROTEASE抑制剂
    • WO1997004004A1
    • 1997-02-06
    • PCT/GB1996001707
    • 1996-07-17
    • PEPTIDE THERAPEUTICS LIMITEDJOHNSON, TonyHART, TerranceLAING, PeterSHAKIB, FaroukQUIBELL, Martin
    • PEPTIDE THERAPEUTICS LIMITED
    • C07K05/06
    • C07K5/06052A61K38/00
    • The invention relates to compounds for use in the treatment of allergic diseases including juvenile asthma and eczema. The compounds can inhibit IgE mediated reaction to major environmental and occupational allergens. They can also have a prophylactic effect against allergic disease by preventing allergic sensitisation to environmental and occupational antigens when administered to at-risk individuals (e.g. those at genetic risk of asthma, and those exposed to occupational allergens in the workplace). The compounds of the invention can also be useful for inactivation or attenuation of the allergenicity of allergens in situ. The invention provides novel compounds and ligands per se, pharmaceutical compositions containing the compounds, processes for producing the compounds and pharmaceutical compositions, and methods for using the compounds and compositions in treatment or prophylaxis of IgE mediated allergic diseases and in inactivation or attenuation of allergens in situ. The invention also provides means for the reducing or destroying the viability of allergy-causing organisms.
    • 本发明涉及用于治疗过敏性疾病(包括幼年型哮喘和湿疹)的化合物。 这些化合物可以抑制IgE介导的对主要环境和职业过敏原的反应。 当对有风险的个体(例如那些患有哮喘的遗传风险和在工作场所暴露于职业过敏原的人)施用时,它们也可以通过防止对环境和职业抗原的过敏敏化来预防过敏性疾病。 本发明的化合物还可用于失活或减轻原位过敏原的致敏性。 本发明提供了新的化合物和配体本身,含有化合物的药物组合物,用于生产化合物的方法和药物组合物,以及使用该化合物和组合物治疗或预防IgE介导的过敏性疾病和灭活或减弱变应原的方法 原位。 本发明还提供了减少或破坏过敏生物的活力的方法。